pliant therapeutics

Third Rock funnels $45M into Pliant Therapeutics to develop small molecule drugs for fibrosis

It plans to bring its idiopathic pulmonary fibrosis small molecule to the clinic in the next two years.

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

BioPharma

BioLabs Pegasus Park Cultivates Life Science Ecosystem

Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.